Avion Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$925K Buy
772
+45
+6% +$46K 0.17% 42
2026
Q1
$668K Sell
727
-18
-2% -$18.2K 0.14% 45
2025
Q4
$800K Buy
745
+44
+6% +$42.1K 0.17% 41
2025
Q3
$534K Sell
701
-33
-4% -$24.6K 0.11% 50
2025
Q2
$572K Buy
734
+56
+8% +$43.5K 0.13% 47
2025
Q1
$523K Hold
678
0.13% 48
2024
Q4
$523K Sell
678
-23
-3% -$19K 0.13% 48
2024
Q3
$621K Buy
701
+8
+1% +$7.19K 0.16% 41
2024
Q2
$627K Buy
693
+18
+3% +$14.4K 0.17% 40
2024
Q1
$526K Sell
675
-326
-33% -$232K 0.14% 43
2023
Q4
$584K Sell
1,001
-53
-5% -$30.9K 0.16% 42
2023
Q3
$565K Buy
1,054
+12
+1% +$6.18K 0.16% 44
2023
Q2
$488K Buy
1,042
+34
+3% +$14.3K 0.13% 46
2023
Q1
$368K Buy
1,008
+205
+26% +$69.1K 0.1% 49
2022
Q4
$259K Hold
803
0.08% 55
2022
Q3
$260K Hold
803
0.08% 55
2022
Q2
$260K Buy
803
+55
+7% +$16.5K 0.08% 54
2022
Q1
$214K Hold
748
0.06% 56
2021
Q4
$207K Hold
748
0.06% 56
2021
Q3
$173K Hold
748
0.05% 55
2021
Q2
$172K Hold
748
0.05% 55
2021
Q1
$140K Hold
748
0.05% 52
2020
Q4
$126K Hold
748
0.04% 56
2020
Q3
$111K Hold
748
0.04% 57
2020
Q2
$123K Sell
748
-76
-9% -$11.7K 0.04% 47
2020
Q1
$114K Buy
+824
New +$113K 0.05% 45

Other funds holding LLY

Avion Wealth's LLY Position: Q2 2026 in Review

Avion Wealth increased its Eli Lilly (LLY) stake by 6.2% in Q2 2026, buying an estimated $46K and bringing the position to 772 shares worth $925K. The position accounts for 0.17% of the portfolio, ranked #42.

Avion Wealth first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Avion Wealth held 772 shares of Eli Lilly worth $925K as of Q2 2026.
  • Avion Wealth bought 45 Eli Lilly shares in Q2 2026, an estimated $46K.
  • Eli Lilly made up 0.17% of Avion Wealth's portfolio in Q2 2026, its #42 holding.
  • Avion Wealth first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.